Supergene, Llc
Clinical trials sponsored by Supergene, Llc, explained in plain language.
-
Massive study tests new clot-buster for deadly lung condition
Disease control Recruiting nowThis study is testing a drug called non-immunogenic staphylokinase in 20,000 adults with a massive blood clot in the lungs (pulmonary embolism). The goal is to see if the drug can safely break up the clot and lower the risk of death or other serious problems. Participants will re…
Sponsor: Supergene, LLC • Aim: Disease control
Last updated May 26, 2026 08:09 UTC
-
New drug could save limbs without surgery in major trial
Disease control Recruiting nowThis study tests whether a clot-dissolving drug called Fortelyzin® can save limbs as well as emergency surgery in people with acute limb ischemia—a sudden blockage of blood flow to a leg. About 170 adults with moderate-to-severe ischemia will receive either the drug directly into…
Phase: PHASE3 • Sponsor: Supergene, LLC • Aim: Disease control
Last updated May 18, 2026 12:06 UTC
-
One shot could save lives: new drug trial for lung clots begins
Disease control Recruiting nowThis study tests a single-dose medicine (staphylokinase) to see if it can prevent death, heart failure, or repeat blood clots in people with a serious type of pulmonary embolism. About 486 adults with intermediate high-risk clots will receive either the drug or a placebo. The goa…
Phase: PHASE3 • Sponsor: Supergene, LLC • Aim: Disease control
Last updated May 14, 2026 12:03 UTC